temotrust TEMOZOLOMIDE

Introduction to temotrust

Temotrust is a medication available in tablet form, primarily used to treat certain aggressive brain tumors. Temotrust is specifically indicated for conditions such as glioblastoma multiforme and anaplastic astrocytoma, which are types of cancer affecting the brain.

Composition of temotrust

Temotrust contains the active ingredient Temozolomide, which belongs to a class of drugs known as alkylating agents. These agents work by adding an alkyl group to the DNA of cancer cells, causing damage that prevents the cells from growing and dividing.

Uses of temotrust

• Treatment of glioblastoma multiforme
• Treatment of anaplastic astrocytoma

Side effects of temotrust

• Common side effects: nausea, vomiting, fatigue
• Serious side effects: severe bone marrow suppression, increased risk of infection

Precautions of temotrust

Temotrust can lower blood cell counts, increasing the risk of infections. It is not recommended for use during pregnancy due to potential harm to the unborn baby. Patients with severe bone marrow suppression should avoid using this medication.

How to Take temotrust

Temotrust is taken orally, usually as a tablet. The typical starting dose for adults is 150 mg/m² once daily for five days in a 28-day cycle. It should be taken on an empty stomach, either one hour before or two hours after a meal. Always follow your doctor’s advice for the correct usage.

Conclusion of temotrust

Temotrust, containing the active ingredient Temozolomide, is part of the alkylating agents therapeutic class. It is primarily used to treat aggressive brain tumors such as glioblastoma multiforme and anaplastic astrocytoma. Manufactured with precision, temotrust offers a targeted approach to cancer treatment. Always consult with a healthcare professional for personalized advice and guidance on using temotrust effectively.